Biocon has reported results for the fourth quarter (Q4FY26) and year ended March 31, 2026.

The company has reported over two-fold jump in its net profit at Rs 51.00 crore for the quarter under review as compared to Rs 21.20 crore for the same quarter in the previous year. However, total income of the company has decreased by 7.36% at Rs 654.50 crore for Q4FY26 as compared to Rs 706.50 crore for the corresponding quarter previous year. On consolidated basis, the company has reported 63.45% fall in its net profit at Rs 125.90 crore for the fourth quarter ended March 31, 2026 as compared to Rs 344.50 crore for the same quarter in the previous year. However, the total income of the company increased by 2.59% at Rs 4,569.10 crore for Q4FY26 as compared to Rs 4,453.90 crore for the corresponding quarter previous year. For the year ended March 31, 2026, the company has reported 93.89% fall in its net profit at Rs 37.20 crore as compared to Rs 609.30 crore for the previous year. However, the total income of the company has increased by 7.29% at Rs 2,666.10 crore for year under review as compared to Rs 2,484.90 crore for year ended March 31, 2025. For the year ended March 31, 2026, on the consolidated basis, the company has reported 61.95% fall in its net profit at Rs 385.60 crore as compared to Rs 1,013.30 crore for the previous year. However, the total income of the company increased by 4.85% at Rs 17,269.50 crore for year under review as compared to Rs 16,469.90 crore for year ended March 31, 2025.